Jingyuan Wan

4.3k total citations
112 papers, 3.5k citations indexed

About

Jingyuan Wan is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Jingyuan Wan has authored 112 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 28 papers in Pharmacology and 24 papers in Immunology. Recurrent topics in Jingyuan Wan's work include Drug-Induced Hepatotoxicity and Protection (21 papers), Liver Disease Diagnosis and Treatment (16 papers) and Immune Response and Inflammation (10 papers). Jingyuan Wan is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (21 papers), Liver Disease Diagnosis and Treatment (16 papers) and Immune Response and Inflammation (10 papers). Jingyuan Wan collaborates with scholars based in China, United States and France. Jingyuan Wan's co-authors include Xia Gong, Hongzhong Li, Rong Jiang, Ge Kuang, Li Zhang, Hongyuan Li, Zhuo Zhang, Liangke Zhang, Dan Lin and Fuling Luo and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

Jingyuan Wan

106 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingyuan Wan China 38 1.3k 636 502 430 419 112 3.5k
Youwei Xu China 43 2.4k 1.8× 631 1.0× 406 0.8× 533 1.2× 313 0.7× 119 4.4k
Hua Yu China 33 1.8k 1.3× 400 0.6× 426 0.8× 258 0.6× 445 1.1× 121 3.9k
Qing Zhang China 35 2.1k 1.6× 499 0.8× 486 1.0× 333 0.8× 390 0.9× 135 4.5k
Shengpeng Wang Macao 35 1.8k 1.4× 541 0.9× 290 0.6× 181 0.4× 533 1.3× 94 3.7k
Gang Cao China 31 2.0k 1.5× 480 0.8× 301 0.6× 374 0.9× 496 1.2× 145 4.2k
Seong‐Ho Lee United States 37 1.7k 1.3× 346 0.5× 469 0.9× 275 0.6× 240 0.6× 100 4.0k
Xiangchun Shen China 29 1.3k 1.0× 384 0.6× 253 0.5× 187 0.4× 285 0.7× 200 2.9k
Vincent Kam Wai Wong Macao 39 2.5k 1.9× 403 0.6× 335 0.7× 781 1.8× 331 0.8× 183 4.5k
Xu Wu China 37 2.4k 1.8× 541 0.9× 628 1.3× 273 0.6× 448 1.1× 138 4.5k
Ashraf B. Abdel‐Naim Egypt 37 1.3k 1.0× 540 0.8× 170 0.3× 254 0.6× 436 1.0× 168 4.2k

Countries citing papers authored by Jingyuan Wan

Since Specialization
Citations

This map shows the geographic impact of Jingyuan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyuan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyuan Wan more than expected).

Fields of papers citing papers by Jingyuan Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyuan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyuan Wan. The network helps show where Jingyuan Wan may publish in the future.

Co-authorship network of co-authors of Jingyuan Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyuan Wan. A scholar is included among the top collaborators of Jingyuan Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyuan Wan. Jingyuan Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuang, Ge, Jun Hu, Hui Du, et al.. (2025). PROM2 exacerbates CCl4-Induced liver fibrosis via NLRP3 inflammasome activation and hepatocyte pyroptosis. Cellular and Molecular Life Sciences. 82(1). 403–403.
2.
Yin, Xinru, Meng Liu, Yan‐Ming Xu, et al.. (2025). Macrophage-derived DLL4 promotes liver fibrosis by activating the Notch pathway in hepatic stellate cells. Free Radical Biology and Medicine. 242. 431–443.
3.
Chen, Yisheng, et al.. (2025). Advanced lung cancer inflammation index as a new predictor for colon cancer in elderly patients: an NHANES-based study. Frontiers in Nutrition. 12. 1642913–1642913.
4.
Tie, Hongtao, Ge Kuang, Xia Gong, et al.. (2024). LXA4 protected mice from renal ischemia/reperfusion injury by promoting IRG1/Nrf2 and IRAK-M-TRAF6 signal pathways. Clinical Immunology. 261. 110167–110167. 3 indexed citations
5.
Wang, Dehua, et al.. (2024). Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis. Free Radical Biology and Medicine. 217. 29–47. 5 indexed citations
6.
Tong, Shiwen, Ge Kuang, Xia Gong, et al.. (2023). Sesamin Protects against APAP-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Inflammatory Response via Deactivation of HMGB1/TLR4/NFκB Signal in Mice. Journal of Immunology Research. 2023. 1–15. 9 indexed citations
7.
Wang, Ting, et al.. (2023). Identification and Analysis of Neutrophil Extracellular Trap-Related Genes in Osteoarthritis by Bioinformatics and Experimental Verification. Journal of Inflammation Research. Volume 16. 3837–3852. 18 indexed citations
8.
9.
Guo, Peipei, Jun-Xia Yang, Xinru Yin, et al.. (2022). MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice. Mediators of Inflammation. 2022. 1–13. 8 indexed citations
10.
Zhou, Xu, Ge Kuang, Rong Jiang, et al.. (2021). Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1 in mice. Journal of Pharmacy and Pharmacology. 73(3). 338–346. 20 indexed citations
11.
Zhang, Xiaojiao, Fuling Luo, Jing Li, et al.. (2018). DNA damage‐inducible transcript 4 is an innate guardian for human squamous cell carcinoma and an molecular vector for anti‐carcinoma effect of 1,25(OH)2D3. Experimental Dermatology. 28(1). 45–52. 13 indexed citations
12.
13.
Lin, Dan, Ge Kuang, Jingyuan Wan, et al.. (2016). Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression. Oncology Reports. 37(2). 895–902. 99 indexed citations
14.
Huang, Jing, Bing Yang, Tingxiu Xiang, et al.. (2015). Diallyl disulfide inhibits growth and metastatic potential of human triple‐negative breast cancer cells through inactivation of the β‐catenin signaling pathway. Molecular Nutrition & Food Research. 59(6). 1063–1075. 71 indexed citations
15.
Lin, Ling, Pu Ge, Jie Dai, et al.. (2015). Caloric restriction mimetic 2-deoxyglucose alleviated lethal liver injury induced by lipopolysaccharide/d-galactosamine in mice. Biochemical and Biophysical Research Communications. 459(3). 541–546. 8 indexed citations
16.
Wang, Bin, et al.. (2014). Mangiferin attenuates renal ischemia-reperfusion injury by inhibiting inflammation and inducing adenosine production. International Immunopharmacology. 25(1). 148–154. 27 indexed citations
17.
Li, Hongzhong, Bing Yang, Jing Huang, et al.. (2013). Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicology Letters. 220(3). 219–228. 105 indexed citations
18.
Xie, Jun, et al.. (2012). Upregulation of Sirt1 in carbon-tetrachloride–induced acute liver injury. Drug and Chemical Toxicology. 36(3). 277–283. 11 indexed citations
19.
Wang, Bin, Xia Gong, Jingyuan Wan, et al.. (2011). Resolvin D1 protects mice from LPS-induced acute lung injury. Pulmonary Pharmacology & Therapeutics. 24(4). 434–441. 153 indexed citations
20.
Zhang, Li, Ping Wu, Ping Yuan, et al.. (2007). Lipoxin A4 negatively regulates lipopolysaccharide-induced differentiation of RAW264.7 murine macrophages into dendritic-like cells. Chinese Medical Journal. 120(11). 981–987. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youwei Xu Breakdown of academic impact, for papers by Hua Yu Breakdown of academic impact, for papers by Qing Zhang Breakdown of academic impact, for papers by Shengpeng Wang Breakdown of academic impact, for papers by Gang Cao Breakdown of academic impact, for papers by Seong‐Ho Lee Breakdown of academic impact, for papers by Xiangchun Shen Breakdown of academic impact, for papers by Vincent Kam Wai Wong Breakdown of academic impact, for papers by Xu Wu Breakdown of academic impact, for papers by Ashraf B. Abdel‐Naim
Rankless by CCL
2026